Methocarbamol Injection
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Methocarbamol Injection is a sterile solution of Methocarbamol in an aqueous solution of Polyethylene Glycol 300. It contains NLT 95.0% and NMT 105.0% of the labeled amount of methocarbamol (C11H15NO5).
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K (CN 1-May-2020)
Sample: Mix a volume with 40 mL of water equivalent to 500 mg of methocarbamol from Injection in a small separator. Extract with 10 mL of ethyl acetate, and dry the ethyl acetate layer over anhydrous sodium sulfate. Evaporate the ethyl acetate with the use of a water bath maintained at 40° under a stream of nitrogen to dryness.
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Procedure
Buffer: 6.8 g/L of monobasic potassium phosphate in water. Adjust with phosphoric acid or potassium hydroxide to a pH of 4.5.
Mobile phase: Methanol and Buffer (30:70)
Standard solution: 1 mg/mL of USP Methocarbamol RS in Mobile phase
Sample solution: Nominally 1 mg/mL of methocarbamol from a suitable volume of Injection containing NLT 100 mg of methocarbamol in Mobile phase
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 274 nm
Column: 4.6-mm × 10.0-cm; 3-μm or 5-μm packing L1
Column temperature: 30°
Flow rate: 1 mL/min
Injection volume: 20 μL
System suitability
Sample: Standard solution
Suitability requirements
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of methocarbamol (C11H15NO5) in the portion of Injection taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Methocarbamol RS in the Standard solution (mg/mL)
CU = nominal concentration of methocarbamol in the Sample solution (mg/mL)
Acceptance criteria: 95.0%–105.0%
4 IMPURITIES
Limit of Aldehydes
Diluent: Alcohol and water (20:80)
Solution A: 10 mg/mL of phenylhydrazine hydrochloride in Diluent
Solution B: 10 mg/mL of potassium ferricyanide in water
Solution C: 10 μg/mL of formaldehyde in water prepared as follows. Dissolve 1.37 g of formaldehyde solution in 1 L of water. Dilute 10 mL of the resulting solution with water to 500 mL.
Standard solution: Transfer 4 mL of Solution C to a 25-mL volumetric flask. Add 2.0 mL of filtered Solution A. Allow to stand for 10 min. Add 1mL of Solution B, and allow to stand for 5 min. Add 4 mL of hydrochloric acid, and dilute with alcohol to volume.
Sample solution: Empty the contents of NLT 10 vials of Injection to a suitable container. Transfer 4.0 mL of the composite sample of Injection to a 25-mL volumetric flask. Add 2.0 mL of filtered Solution A, and allow to stand for 10 min. Add 1 mL of Solution B, and allow to stand for 5 min. Add 4 mL of hydrochloric acid, and dilute with alcohol to volume.
Blank: Transfer 4 mL of water to a 25-mL volumetric flask. Add 2.0 mL of filtered Solution A, and allow to stand for 10 min. Add 1 mL of Solution B, and allow to stand for 5 min. Add 4 mL of hydrochloric acid, and dilute with alcohol to volume.
Instrumental conditions
Mode: Vis
Analytical wavelength: 515 nm
Cell: 1 cm
Analysis
Samples: Standard solution, Sample solution, and Blank
Determine the absorbances of the Samples.
Acceptance criteria: The absorbance of the Sample solution is NMT the absorbance of the Standard solution (NMT 10 μg of formaldehyde in each mL of Injection).
5 SPECIFIC TESTS
pH 〈791〉: 3.5–6.0
Bacterial Endotoxins Test 〈85〉: NMT 0.2 USP Endotoxin Units/mg of methocarbamol
Particulate Matter in Injections 〈788〉: Meets the requirements for small-volume injections
Other Requirements: Meets the requirements in Injections and Implanted Drug Products 〈1〉
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in single-dose containers. Store at controlled room temperature.
USP Reference Standards 〈11〉
USP Methocarbamol RS

